-The Times of India NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular diseases as well as antibiotics. "There is a need to review the implementation of DPCO (Drugs Price...
More »SEARCH RESULT
Total Matching Records found : 85
Medicines for diabetes, infections to cost 40% less -Rupali Mukherjee & Sushmi Dey
-The Times of India MUMBAI/NEW DELHI: Medicines widely used to treat diabetes, infections, pain and digestive disorders will cost 5-40% less with immediate effect, with the drug price regulator issuing an order to fix the prices of 39-odd formulations. The National Pharmaceutical Pricing Authority's (NPPA) order, issued on Wednesday, includes drug combinations such as ciprofloxacin hydrochloride, cefotaxime, paracetamol, domperidone and metformin + glimepiride and amoxycillin + potassium clavulanate. These drugs and combinations are...
More »No Medicine for the Common ‘Jan’ -Archana Mishra
-Tehelka The NDA government’s move to open more Jan Aushadhi stores ignores the multitude of issues currently plaguing them Amidst the jostling crowd at the Guru Teg Bahadur Hospital in Shahdara, Delhi, is 68-year-old Suresh Chandra, holding his medical files on one hand and prescription letter on the other. Chandra, who is a lung disease patient, moves towards the Jan Aushadhi store, situated in the hospital premises. Chandra hopes that the government-run medical...
More »Medical devices like stents, implants set to come under price control -Rupali Mukherjee
-The Times of India MUMBAI: Faced with complaints of overpricing of medical devices like cardiac stents and implants, the government seems to be finally getting its act together. According to a government official, in a string of measures to regulate the industry under the Draft National Medical Device Policy, it has recommended creating an autonomous body — the National Medical Devices Authority (NDMA) — pricing control for medical devices by including them...
More »TB, diabetes drug prices to fall by 30% -Sushmi Dey
-The Times of India NEW DELHI: The drug price regulator has capped prices of 30 medicines including antibiotics and those used in treatment of diabetes, tuberculosis and malaria. The move is expected to bring down prices of most of these medicines by 25-30%. However, in some cases the reduction could be by as much as 50%. The National Pharmaceutical Pricing Authority (NPPA), which has the mandate to regulate prices of essential medicines,...
More »
